Health Care & Life Sciences » Pharmaceuticals | Samsung Pharmaceutical Co. Ltd.

Samsung Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
46,921
30,288
42,165
47,194
41,919
46,484
Cost of Goods Sold (COGS) incl. D&A
28,724
20,847
29,405
38,102
35,523
36,201
Gross Income
18,197
9,441
12,760
9,093
6,397
10,283
SG&A Expense
29,320
28,917
14,232
14,943
13,909
14,926
EBIT
11,418
-
1,870
-
7,774
5,399
Unusual Expense
-
1,290
875
7,245
682
1,310
Non Operating Income/Expense
4,370
1,163
3,242
1,644
611
2,184
Interest Expense
2,702
1,485
3,016
2,456
2,590
1,357
Pretax Income
18,489
23,748
654
17,348
10,966
2,016
Income Tax
-
-
341
130
3,692
60
Consolidated Net Income
18,489
23,748
994
17,218
7,274
2,076
Net Income
18,489
23,748
994
17,218
7,274
2,076
Net Income After Extraordinaries
18,489
23,748
994
12,818
7,008
2,076
Net Income Available to Common
18,489
23,748
994
21,618
9,946
2,076
EPS (Basic)
1,424.43
1,112.91
33.28
604.62
172.88
40.51
Basic Shares Outstanding
13
21
30
36
44
51
EPS (Diluted)
1,424.65
1,113.10
33.24
604.31
172.97
40.51
Diluted Shares Outstanding
13
21
30
36
44
51
EBITDA
10,042
18,347
608
3,011
3,859
1,635
Other Operating Expense
295
344
398
476
262
756
Non-Operating Interest Income
2
11
116
324
692
1,246
Minority Interest Expense
-
-
-
-
-
-

About Samsung Pharmaceutical Co.

View Profile
Address
35 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
Employees -
Website http://www.sspharm.co.kr
Updated 07/08/2019
Samsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. It operates through the following business divisions: Pharmaceutical, Cosmetics, and Healthy Food. The Pharmaceutical divsion provides medicines for digestion, antibiotics, intestine, alleviation of fever, and cerebral apoplexy.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.